Literature DB >> 1319194

Intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment.

R T Schlinkert1, D M Nagorney, J A Van Heerden, M A Adson.   

Abstract

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary tumor of the liver. To further define its clinicopathology and surgical management, we reviewed our experience. Clinical presentations of 32 patients with ICC was similar to that with hepatocellular carcinoma. Jaundice occurred in only 27 percent. ICC was unresectable due to advanced disease stage in 81 percent. Six patients had curative resections with two 5 year disease free survivors. Underlying liver disease was associated with ICC in 34 percent of patients.

Entities:  

Mesh:

Year:  1992        PMID: 1319194      PMCID: PMC2442948          DOI: 10.1155/1992/93976

Source DB:  PubMed          Journal:  HPB Surg        ISSN: 0894-8569


  10 in total

1.  Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.

Authors:  Upama Liengswangwong; Anant Karalak; Yukio Morishita; Masayuki Noguchi; Thiravud Khuhaprema; Petcharin Srivatanakul; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

Review 2.  The technical aspects of ex vivo hepatectomy with autotransplantation: a systematic review and meta-analysis.

Authors:  Maria Baimas-George; Kyle J Thompson; Michael D Watson; David A Iannitti; John B Martinie; Erin H Baker; David Levi; Dionisios Vrochides
Journal:  Langenbecks Arch Surg       Date:  2021-02-16       Impact factor: 3.445

3.  Surgery and chemotherapy for intrahepatic cholangiocarcinoma.

Authors:  Zenichi Morise; Atsushi Sugioka; Takamasa Tokoro; Yoshinao Tanahashi; Yasuhiro Okabe; Tadashi Kagawa; Chinatsu Takeura
Journal:  World J Hepatol       Date:  2010-02-27

4.  Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases.

Authors:  J R Madariaga; S Iwatsuki; S Todo; R G Lee; W Irish; T E Starzl
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

5.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

6.  Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.

Authors:  Young-Jin Kim; Mijin Yun; Woo Jung Lee; Kyung Sik Kim; Jong Doo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-07       Impact factor: 9.236

7.  Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma.

Authors:  Shohachi Suzuki; Takanori Sakaguchi; Yoshihiro Yokoi; Kazuya Okamoto; Kiyotaka Kurachi; Yasuo Tsuchiya; Takuya Okumura; Hiroyuki Konno; Satoshi Baba; Satoshi Nakamura
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

8.  Surgical treatment of cholangiocellular carcinoma.

Authors:  R Pichlmayr; P Lamesch; A Weimann; G Tusch; B Ringe
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

Review 9.  A metastatic skull tumor from intrahepatic cholangiocarcinoma: A case report and literature review.

Authors:  Dawei Wang; Shiwei He; Liang Chu; Qing Chao; Qiujian Zhang; Hansheng Shu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

10.  Integrated Bioinformatics analysis and clinical validation reveals that high expression of mucin 1 in intrahepatic cholangiocarcinoma predicts recurrence after curative resection.

Authors:  Fei-Yu Chen; Cheng Zhou; Xiang-Yu Zhang; Kai-Qian Zhou; Yuan-Fei Peng; Lei Yu; Jia Fan; Jian Zhou; Jie Hu; Zheng Wang
Journal:  Exp Ther Med       Date:  2020-09-03       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.